Company Description
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy.
The company operates in two segments, Cardiovascular and Endoscopy.
It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems.
In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures.
The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally.
Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Country | United States |
IPO Date | May 14, 1990 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 6,950 |
CEO | Fred P. Lampropoulos |
Contact Details
Address: 1600 West Merit Parkway South Jordan, Utah United States | |
Website | https://www.merit.com |
Stock Details
Ticker Symbol | MMSI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000856982 |
CUSIP Number | 589889104 |
ISIN Number | US5898891040 |
Employer ID | 87-0447695 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Fred P. Lampropoulos | Founder, Chief Executive Officer & Chairman |
Brian G. Lloyd J.D. | Chief Legal Officer & Corporate Secretary |
Jason Treft | Chief Information Officer |
Neil W. Peterson | Chief Operating Officer |
Raul Parra Jr., CPA | Chief Financial Officer & Treasurer |
JoAnne Alkire | Executive Vice President of Global Marketing & Strategy |
John Knorpp | Chief Regulatory Affairs Officer |
Joseph C. Wright | President |
Michel J. Voigt | Chief Human Resources Officer |
Sarah Comstock | Vice President of Global Communications |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 18, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | 4 | Filing |
Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | 4 | Filing |
Nov 07, 2024 | 4 | Filing |
Nov 01, 2024 | 8-K | Current Report |
Oct 30, 2024 | 10-Q | Quarterly Report |
Oct 30, 2024 | 8-K | Current Report |
Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |